I was told by CYGX mgt. that the latest animal test and subsequent PR was at the request of the FDA from the pre-clinical meeting. CYGX is jumping through the hoops because they have to and I am sure that is the reason for the delay in clinicals. Patience is a virtue.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.